首页> 外文OA文献 >Modeling High-grade serous ovarian carcinoma using a combination of in vivo electroporation and CRISPR/Cas9 mediated genome editing

【2h】

Modeling High-grade serous ovarian carcinoma using a combination of in vivo electroporation and CRISPR/Cas9 mediated genome editing

机译：使用体内电穿孔和CRISPR / CAS9介导的基因组编辑的组合来建模高级浆液卵巢癌

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Katie Teng; Mathew Ford; Keerthana Harwalkar; YuQi Li; David Farnell; Nobuko Yamanaka; Ton Nu Tuyet Nhung; David Huntsman; Jocelyne Arseneau; Yojiro Yamanaka;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. CRISPR/Cas9-Mediated Trp53 and Brca2 Knockout to Generate Improved Murine Models of Ovarian High-Grade Serous Carcinoma [J] . Walton Josephine, Blagih Julianna, Ennis Darren, Cancer research: The official organ of the American Association for Cancer Research, Inc . 2016,第20期

机译：CRISPR / Cas9介导的Trp53和Brca2敲除可产生卵巢高级别浆液性癌的改良鼠模型
2. A Lactose‐Derived CRISPR/Cas9 Delivery System for Efficient Genome Editing In Vivo to Treat Orthotopic Hepatocellular Carcinoma [J] . Yu Qi, Yanli Liu, Bingran Yu, Advanced Science . 2020,第17期

机译：用于治疗原位肝细胞癌的有效基因组编辑的乳糖衍生的CRISPR / CAS9输送系统，以治疗原位肝细胞癌
3. The Development of a Viral Mediated CRISPR/Cas9 System with Doxycycline Dependent gRNA Expression for Inducible In vitro and In vivo Genome Editing [J] . Christopher A. de Solis, Anthony Ho, Roopashri Holehonnur, Frontiers in Molecular Neuroscience . 2016,第2期

机译：具有强力霉素依赖性gRNA表达的病毒介导的CRISPR / Cas9系统的开发，可诱导体外和体内基因组编辑
4. Agrobacterium-mediated transformation facillitates the CRISPR/Cas9 genome editing system in Dendrobium macrophyllum A. Rich orchid [C] . Yuli Setiawati, Sri Nopitasari, Muhammad Dylan Lawrie, International Conference on Biological Science . 2020

机译：农杆菌介导的转化突出了石斛兰果岭A.富含兰花的CRISPR / CAS9基因组编辑系统
5. Generation of Hemophilia B Model Hepatocytes Derived from Human IPSC via CRISPR/Cas9 Mediated Genome Editing [D] . Kwak, Peter 2018

机译：通过CRISPR / CAS9介导的基因组编辑产生血友病B模型肝细胞衍生自人IPSC
6. A Lactose‐Derived CRISPR/Cas9 Delivery System for Efficient Genome Editing In Vivo to Treat Orthotopic Hepatocellular Carcinoma [O] . Yu Qi, Yanli Liu, Bingran Yu, 2020

机译：用于治疗原位肝细胞癌的有效基因组编辑的乳糖衍生的CRISPR / CAS9输送系统以治疗原位肝细胞癌
7. CRISPR/Cas9-Mediated Trp53 and Brca2 Knockout to Generate Improved Murine Models of Ovarian High-Grade Serous Carcinoma [O] . Walton J, Blagih J, Ennis D, 2016

机译：CRIspR / Cas9介导的Trp53和Brca2基因敲除可产生卵巢高级别浆液性癌的改良小鼠模型

Modeling High-grade serous ovarian carcinoma using a combination of in vivo electroporation and CRISPR/Cas9 mediated genome editing

著录项

引文网络

相似文献

相关主题

期刊订阅